UPDATE 1-FDA panel to focus on safety of Novartis gene therapy … – Business Insider
|
UPDATE 1-FDA panel to focus on safety of Novartis gene therapy …
Business Insider July 10 (Reuters) – The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG’s experimental gene therapy drug … Novartis’ CAR-T Therapy for Pediatric Leukemia to Face FDA Advisory PanelAJMC.com Managed Markets Network |
BU Today |
CReM Stem Cell Researcher Is Innovator of the Year
BU Today Those who know ancient history—the first decade of the 21st century—recall that embryonic stem cell research was a combustible issue, with supporters cheering the potential to create new tissues from stem cells and opponents decrying the destruction … |
|
上海生科院建立高效谷氨酸棒杆菌CRISPR-Cpf1基因组编辑系统
上海科技 5月4日，《自然-通讯》（Nature Communications）发表了中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室杨晟研究组题为CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum 的 … |
|
上海生科院建立高效谷氨酸棒杆菌CRISPR-Cpf1基因组编辑系统
上海科技 5月4日，《自然-通讯》（Nature Communications）发表了中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室杨晟研究组题为CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum 的 … |
|
上海生科院建立高效谷氨酸棒杆菌CRISPR-Cpf1基因组编辑系统
上海科技 5月4日，《自然-通讯》（Nature Communications）发表了中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室杨晟研究组题为CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum 的 … |
The Scientist |
Major CRISPR Patent-Holders Agree to Patent Pool
The Scientist Groups seeking to commercialize CRISPR technology are often required to go to more than one institution for licensing, according to the Broad’s statement, given that there are 18 different organizations in the U.S. that hold more than 60 CRISPR-Cas9 … |